Medical Cannabis
Science-led insight on therapeutic use, formulations, and clinical best practice.
Medical Cannabis · page 9
- International Regulation
Inside Australia’s Medical Cannabis Boom: Prescriptions, Products & Patients
Australia’s thriving medical cannabis industry has continued its blistering levels of growth, seeing the amount of medical cannabis imported grow nearly tenfold in just three years, according to new official data.
- Medical Cannabis
Import Approvals Paused as Germany Hits 2025 Medical Cannabis Limit
The Federal Institute for Drugs and Medical Devices (BfArM) has announced that Germany’s estimated annual demand for medical cannabis in 2025 has already been reached, leading to a temporary suspension of new import licences.
- Medical Cannabis
German Political Divide Deepens Over Interim Cannabis Report Findings
Last week, Business of Cannabis reported on the publication of Germany’s first official evaluation of its Recreational Cannabis Act (KCanG) and the early data suggesting limited social and health impacts from legalisation.
- International Regulation
Hope for Thailand: ‘Cannabis Champion’ Anutin Charnvirakul Becomes Prime Minister
Thailand’s political landscape has seen three changes of power in just one year, the latest being the removal of Paetongtarn Shinawatra, daughter of former prime minister Thaksin Shinawatra, over her handling of a border conflict with Cambodia.
- Medical Cannabis
News Round-Up: 500m People With Access To Adult-Use Cannabis, THC Content In German Clubs 18.6%, UK Launches First Cannabis Review for Seven Years
A NEW survey of over 200 of Germany’s Cannabis Social Clubs finds the average number of members is 275, and the average age 36.
- Legal Analysis
How Has the UK Government’s Position on Cannabis Changed Under Labour?
The UK’s cannabis industry, one of the largest on the planet, sits at a crossroads.
- Industry Trends
“A Brick Wall for Every Patient”: GOP Bill Threatens Medical Cannabis Protections, Blocking Rescheduling in the Process
US Republicans have sharpened their sights on cannabis rescheduling, advancing legislation that would not only stop any hope of rescheduling in its tracks, but also potentially remove existing protections for medical cannabis dispensaries across the US.
- Legal Analysis
£13.3 Billion Boost: Medical Cannabis Expansion Touted as Solution to NHS Woes
Expanding NHS access to medical cannabis could add £13.3bn to the UK economy over 10 years, easing NHS costs and reducing long-term sickness.
- Industry Trends
Patients, Companies and Platforms Oppose Tightening of the CanG
Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the previous traffic-light coalition, which marked a paradigm shift in cannabis policy.
- Cultivation
Germany as Europe’s Beacon: How Enua Is Securing Medical Cannabis Amid Legalization Shifts
In the latest instalment of our series spotlighting the expert contributors to Prohibition Partners’ newly launched Insights Hub, we sat down with Enua to dicsuss the risks posed by Germany’s drift towards adult-use in its medical market, the company’s proposals for strengthening pharmacy-led distribution and introducing over-the-counter cannabis products, and its long-term mission to ensure…
- Medical Cannabis
Implementation Questionable: Federal Drug Commissioner Calls for Stricter Rules on Cannabis Medicine
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June had spoken only vaguely about the partial legalisation of cannabis, has since taken a sharper stance.
- Medical Cannabis
Inside Slovenia’s New ‘Revolutionary’ Medical Cannabis Law
Last month, Slovenia’s parliament passed a law to significantly open up access to medical cannabis, coinciding with the presentation of a separate draft law on legalisation for personal use.
